Who owns DEAN JACK H?

No ownership or control links for DEAN JACK H are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.

What is DEAN JACK H's risk level?

WhiteIntel flags DEAN JACK H as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.

Where does DEAN JACK H appear across sources?

DEAN JACK H is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

LIVE · CORPUS

Dossier

●

DEAN JACK H

Name: DEAN JACK H — ownership dossier
Creator: WhiteIntel
License: https://whiteintel.dev/terms
Keywords: corporate ownership, beneficial ownership, UBO, corporate intelligence, OSINT, corporate registry, DEAN JACK H, Person, US

Low

PersonUS

View network JSON / MCPsample

Fig. 01 — Cross-source signature

The finding

Controls or directs 4 companies in the resolved graph.

/01

Key facts

Risk signal

Controls: 4 companies
Risk: Low
Jurisdiction: US

Low

Risk

DEAN JACK H controls or directs 4 companies (US).

/02

Control & directorships

Controlled by

None in current sources.

Directorships & controlled companies

DEAN JACK H
- Acurx Pharmaceuticals, Inc.· director· via sec_form345
- DIPEXIUM PHARMACEUTICALS, INC.· director· via SEC EDGAR
- RESEARCH PHARMACEUTICAL SERVICES, INC.· director· via SEC EDGAR

/03

Directorship network

74 other roles

Where this entity’s officers also hold (or held) positions — the wider network reached through shared people. Roles are registry records, not a claim of control.

Acurx Pharmaceuticals, Inc.

Shawah Robert G.officer
LUCI DAVID P10% owner
DELUCCIA ROBERT J10% owner
Scodari Joseph Cdirector
Sailer Carldirector
LUCI DAVID P10% owner
Donohue James J.director
DELUCCIA ROBERT J10% owner
LUCI DAVID Pofficer
Sailer Carldirector
Shawah Robert G.officer
Donohue James J.director
LUCI DAVID Pdirector
HARRISON THOMAS Ldirector
DELUCCIA ROBERT Jdirector
Scodari Joseph Cdirector
LUCI DAVID Ptenpercentowner
DELUCCIA ROBERT Jtenpercentowner

DIPEXIUM PHARMACEUTICALS, INC.

HADDEN JOHNdirector
GIORDANO NATASHAofficer
VALENTINO MICHAEL Jdirector
BALKEMA GARY S.director
O'CONNOR RITA Mofficer
VALENTINO MICHAEL Jofficer
GIORDANO NATASHAdirector
CASALE ROBERTdirector
LEVEL ONE PARTNERS, LLCtenpercentowner
HARDIE MOLLY G.tenpercentowner
HARDIE ROBERT D.tenpercentowner
CALHOUN KIRK Kdirector
PARK WEST ASSET MANAGEMENT LLCtenpercentowner
Deliargyris Efthymiosofficer
BARTSH ANTHONYdirector
MOSSMAN GARY Lother
HARRISON THOMAS Ldirector
JORDEN DAVID EMERSONtenpercentowner
DELUCCIA ROBERT Jtenpercentowner
MCSHERRY, JR. WILLIAM J.director
MOSSMAN GARY Ltenpercentowner
DILLON MICHAEL J.officer
DELUCCIA ROBERT Jdirector
MOSSMAN GARY Lofficer
LUCI DAVID Pdirector
DELUCCIA ROBERT Jofficer
DUFFY MICHAEL E.director
JORDEN DAVID EMERSONofficer
KAGAN BARRYdirector
Shawah Robert G.officer
LUCI DAVID Pofficer
GARRETT DAVIDofficer
LUCI DAVID Ptenpercentowner
COUGHLIN CHRISTOPHER Jdirector

RESEARCH PHARMACEUTICAL SERVICES, INC.

BELL STEVENofficer
COURNOT ANTOINEofficer
STONEFIELD STEPHEN Edirector
MYERS WARREN Wdirector
ARMSTRONG THOMAS Rtenpercentowner
FIRST ANALYSIS CORP.tenpercentowner
KOFFER HARRISofficer
PERLMAN DANIEL Mdirector
KOFFER HARRISdirector
MACDONALD JAMES Rtenpercentowner
ARGENTUM INVESTMENTS, LLCother
MACDONALD JAMES Rdirector
SHAH SAMIRofficer
ARCANGELO JOSEPH Dofficer
BRENNAN JANET Ldirector
RAYNOR DANIELtenpercentowner
PANGAEA ONE ACQUISITION HOLDING I, LLCtenpercentowner
PERLMAN DANIEL Mofficer
ARGENTUM CAPITAL PARTNERS II, L.P.tenpercentowner
YU PETERtenpercentowner
RAYNOR DANIELdirector
ARGENTUM PARTNERS II, LLCother

Community intel

Crowd leads · unverified

Tips, corrections and leads contributed by the community on DEAN JACK H. These are unverified leads, not WhiteIntel findings — we surface them for investigators to chase, and analyse the corroborated ones into SnakeScore.

Loading tips…